PMA supplement
P950027 S009: HYALGAN
FDA PMA supplement · Normal 180 Day Track · Fidia Farmaceutici S.P.A.
Key facts
| Original PMA | P950027 |
|---|---|
| Supplement number | S009 |
| Supplement type | Normal 180 Day Track |
| Reason for the supplement | Change Design/Components/Specifications/Material |
| Trade name | HYALGAN |
| Generic name | Acid, hyaluronic, intraarticular |
| Applicant | Fidia Farmaceutici S.P.A. |
| Product code | MOZ |
| Received date | Jun 20, 2007 |
| Decision date | May 1, 2008 |
At a glance
- No Expedited review granted
- No Approval order on file
- No Summary of safety and effectiveness on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA supplements
A PMA supplement asks FDA to approve a change to a device that already holds a premarket approval: a new indication, a design or labeling change, a manufacturing site or process change.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: